Phase II trial of sorafenib in esophageal (E) and gastroesophageal junction (GEJ) cancer: Response observed in adenocarcinoma Meeting Abstract
| Authors: | Ilson, D.; Shah, M. A.; Kelsen, D. P.; Janjigian, Y. Y.; Tang, L. H.; Campbell, J.; Fuqua, L. |
| Abstract Title: | Phase II trial of sorafenib in esophageal (E) and gastroesophageal junction (GEJ) cancer: Response observed in adenocarcinoma |
| Meeting Title: | 46th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 28 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2010 Jun 4-8 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2010-05-20 |
| Language: | English |
| ACCESSION: | WOS:000208852000787 |
| DOI: | 10.1200/jco.2010.28.15_suppl.e14668 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: e14668 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
